What if a company’s “stamp” were embedded in your genes? Could you still confidently say: “This body is 100% mine”? Right now, in the worlds of medicine and science, technologies are rapidly emerging that challenge long-held assumptions. Extracellular vesicles—tiny carriers that transport information between cells. Drug delivery systems designed to cross the blood-brain barrier and deliver nucleic acids to the brain. And intellectual property rights surrounding artificially engineered nucleic acids and gene-related technologies. The crucial issue here is not simply this: “Companies can own human beings.” Rather, the real question is this: We are approaching an era in which corporations can design, deliver, and act upon the very information that constitutes life—and then control that technology as intellectual property. In 2013, the U.S. Supreme Court ruled that naturally occurring DNA cannot be patented, but synthetically created cDNA may qualify for patent protection. In agriculture, courts have already debated the scope of patent rights over crops engineered with patented genetic traits. So what if, in the future, “Artificially designed genetic information,” “The technology that delivers it to cells,” “And the therapies that utilize it,” are all integrated into a vast intellectual property system? Companies wouldn’t need to own human bodies at all. They would only need to control the “information” that drives the body—and the “technology” that manipulates it. Once we reach that point, life ceases to be merely physical. It becomes: Readable information → Designable information → Information delivered to cells → Information managed as intellectual property This is still a hypothetical future—but individual technologies behind it are already under active research. That’s why we must ask: Are humans beings who own their own bodies? Or are we becoming platforms whose very bodies can be designed by others? Perhaps humans are not beings born complete— but beings who are continuously designed as they live. *Note: Unintended interhuman transmission of genetic information via extracellular vesicles must be distinguished from proven evidence in humans at this time.*